Discontinuing GLP-1 Receptor Agonist Use Before Pregnancy Tied to Risk for Adverse Outcomes

TUESDAY, Nov. 25, 2025-- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use with subsequent prepregnancy or early pregnancy discontinuation is associated with more gestational weight gain and a higher risk for preterm delivery, gestational...